A Message from the CEO of Aequus Pharmaceuticals

VANCOUVER, British Columbia, March 23, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products,...

SilverCrest arranges $75.07M bought-deal offering

Silvercrest Metals Inc. has entered into an agreement with a syndicate of underwriters led by National Bank Financial Inc., Eight Capital Corp. and Scotia Capital Inc., pursuant to which the underwriters have agreed to purchase, on a bought-deal basis, 9.1 million...